Citadel Advisors’s Allena Pharmaceuticals, Inc. Common Stock ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-37,613
| Closed | -$9K | – | 7419 |
|
|
2022
Q1 | $9K | Buy |
37,613
+7,788
| +26% | +$1.86K | ﹤0.01% | 6220 |
|
|
2021
Q4 | $17K | Sell |
29,825
-17,150
| -37% | -$9.78K | ﹤0.01% | 6328 |
|
|
2021
Q3 | $42K | Sell |
46,975
-655
| -1% | -$586 | ﹤0.01% | 6167 |
|
|
2021
Q2 | $62K | Buy |
+47,630
| New | +$62K | ﹤0.01% | 6143 |
|
|
2020
Q3 | – | Sell |
-16,268
| Closed | -$26K | – | 5495 |
|
|
2020
Q2 | $26K | Sell |
16,268
-5,134
| -24% | -$8.21K | ﹤0.01% | 4460 |
|
|
2020
Q1 | $21K | Buy |
21,402
+7,455
| +53% | +$7.32K | ﹤0.01% | 4659 |
|
|
2019
Q4 | $38K | Buy |
+13,947
| New | +$38K | ﹤0.01% | 4428 |
|
|
2019
Q1 | – | Sell |
-10,970
| Closed | -$60K | – | 5207 |
|
|
2018
Q4 | $60K | Buy |
10,970
+194
| +2% | +$1.06K | ﹤0.01% | 4085 |
|
|
2018
Q3 | $116K | Buy |
+10,776
| New | +$116K | ﹤0.01% | 3874 |
|
|
2018
Q2 | – | Sell |
-11,265
| Closed | -$124K | – | 4715 |
|
|
2018
Q1 | $124K | Buy |
+11,265
| New | +$124K | ﹤0.01% | 3600 |
|